Search research articles
Contact Us
Filters
Showing results (81-90 of 176) with videos related to
Page
of 18
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2007
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
G Ferrandina, M Ludovisi, R De Vincenzo, et al.
British Journal of Cancer
|
September 10, 2009
Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial
G Ferrandina, G Sallustio, A Fagotti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Clinical significance of cathepsin D in primary ovarian cancer
G Scambia, P B Panici, G Ferrandina, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
June 23, 2005
Does quantitative analysis of three-dimensional power Doppler angiography have a role in the diagnosis of malignant pelvic solid tumors? A preliminary study
A C Testa, S Ajossa, G Ferrandina, et al.
British Journal of Cancer
|
May 29, 2008
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients
G Ferrandina, M Petrillo, A Carbone, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
April 21, 2007
The role of CnTI-SonoVue in the diagnosis of ovarian masses with papillary projections: a preliminary study
A C Testa, D Timmerman, C Exacoustos, et al.
Gynecologic Oncology
|
October 23, 2009
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery?
A Fagotti, F Fanfani, G Vizzielli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis
V Masciullo, G Ferrandina, B Pucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2009
Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group
D Lorusso, G Ferrandina, S Pignata, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
April 21, 2007
Imaging in gynecological disease (1): ultrasound features of metastases in the ovaries differ depending on the origin of the primary tumor
A C Testa, G Ferrandina, D Timmerman, et al.
Page
of 18
Search research articles
Search
Showing results (81-90 of 176) with videos related to
Sort By:
Page
of 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 2, 2007
Docetaxel and oxaliplatin in the second-line treatment of platinum-sensitive recurrent ovarian cancer: a phase II study
G Ferrandina, M Ludovisi, R De Vincenzo, et al.
British Journal of Cancer
|
September 10, 2009
Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial
G Ferrandina, G Sallustio, A Fagotti, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1994
Clinical significance of cathepsin D in primary ovarian cancer
G Scambia, P B Panici, G Ferrandina, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
June 23, 2005
Does quantitative analysis of three-dimensional power Doppler angiography have a role in the diagnosis of malignant pelvic solid tumors? A preliminary study
A C Testa, S Ajossa, G Ferrandina, et al.
British Journal of Cancer
|
May 29, 2008
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients
G Ferrandina, M Petrillo, A Carbone, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
April 21, 2007
The role of CnTI-SonoVue in the diagnosis of ovarian masses with papillary projections: a preliminary study
A C Testa, D Timmerman, C Exacoustos, et al.
Gynecologic Oncology
|
October 23, 2009
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery?
A Fagotti, F Fanfani, G Vizzielli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2001
p27Kip1 expression is associated with clinical outcome in advanced epithelial ovarian cancer: multivariate analysis
V Masciullo, G Ferrandina, B Pucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 17, 2009
Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group
D Lorusso, G Ferrandina, S Pignata, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
April 21, 2007
Imaging in gynecological disease (1): ultrasound features of metastases in the ovaries differ depending on the origin of the primary tumor
A C Testa, G Ferrandina, D Timmerman, et al.
Page
of 18